Device Authority strengthens position in machine identity and Zero Trust Security

Tern plc

Device Authority has been named as a representative vendor for IoT Authentication in two Gartner Hype Cycle reports for 2026, covering Digital Identity and Zero-Trust Technology.

The recognition supports the company’s positioning in machine identity security, certificate lifecycle automation and cryptographic trust. These areas are becoming more important as organisations manage growing numbers of connected devices, operational systems and software workloads.

Device Authority’s KeyScaler platform is designed to automate machine identity provisioning, certificate lifecycle management, cryptographic key management and security policy enforcement. The technology is used to establish and maintain trust between devices and systems without relying on manual processes.

This is particularly relevant in environments where large numbers of connected assets need to be authenticated and managed securely. These include industrial systems, operational technology, medical devices, connected products and automotive platforms.

As organisations adopt Zero Trust security models, machine identity becomes a more important part of access control. Zero Trust requires every user, device and system to be verified before access is granted. That increases the need for reliable digital identities and automated management of the certificates and keys that support them.

Device Authority’s technology addresses this requirement by helping organisations control machine identities at scale. Automation can reduce the risk associated with expired certificates, unmanaged credentials and inconsistent security policies across large device estates.

Tern plc (LON:TERN) backs exciting, high growth IoT innovators in Europe. They provide support and create a genuinely collaborative environment for talented, well-motivated teams.

Share on:
Find more news, interviews, share price & company profile here for:

Latest Company News

Talking Medicines targets growing demand for GLP-1 patient intelligence

Talking Medicines is using GLP-1 patient conversations to show how behavioural data can help pharmaceutical companies understand changing treatment expectations and engagement.

Talking Medicines builds its AI strategy around specialist life sciences intelligence

Talking Medicines is positioning specialist healthcare intelligence as the core layer that gives agentic AI useful context in life sciences.

Device Authority targets cyber resilience opportunity at TechWorks Summit 2026

Device Authority will focus on continuous IoT and OT compliance, AI and quantum risk at TechWorks Summit 2026 as it strengthens its position in connected-device security.

Talking Medicines builds a more defensible AI model for life sciences

Talking Medicines is combining proprietary healthcare intelligence, AI agents and orchestration to build a more specialised AI platform for life sciences.

Fundamental XR builds case for wider surgical simulation adoption

Fundamental XR is expanding the role of virtual simulation in surgical training as hospitals integrate the technology into structured education programmes.

Device Authority strengthens position in machine identity and Zero Trust Security

Device Authority’s inclusion in two 2026 Gartner Hype Cycle reports reinforces its positioning in machine identity, IoT authentication and Zero Trust security.

Search